Clinical trials
Phase 2 Endometriosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Terminated | 7 |
| Withdrawn | 4 |
| Active, not recruiting | 3 |
| Recruiting | 1 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Children's Hospital | 5 |
| Repros Therapeutics Inc. | 4 |
| Bayer | 3 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| Mereo BioPharma | 2 |
| University of North Carolina, Chapel Hill | 2 |
| Wake Forest University Health Sciences | 2 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 2 |
| Abbott | 1 |
| Baylor College of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometriosis | 37 |
| Pelvic Pain | 10 |
| Dysmenorrhea | 4 |
| Pain | 4 |
| Chronic Pain | 2 |
| Dyspareunia | 2 |
| Infertility | 2 |
| Uterine Diseases | 2 |
| Back Pain | 1 |
| Cystitis, Interstitial | 1 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.